Trial Profile

A Phase II Study of ABC294640 in Patients With Advanced Hepatocellular Carcinoma Who Have Progressed on Sorafenib

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 25 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Opaganib (Primary)
Indications Liver cancer
Focus Therapeutic Use

Most Recent Events

10 Sep 2019 Planned initiation date changed from 30 Aug 2019 to 30 Sep 2019.
10 Sep 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
09 Jul 2019 Planned initiation date changed from 30 Jun 2019 to 30 Aug 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com